Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center.
Alicia McGhie, Jenessa Lee, Alessandra Ferrajoli, Adam J DiPippoNo abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.